semaglutide vision loss Could drugs for diabetes, obesity affect eyesight? Ozempic Vision Loss: What Patients

Additional findings included: Safety profile consistent with incretin and amylin-based therapies Most adverse events were mild-to-moderate gastrointestinal events Both oral and subcutaneous formulations under development Phase 3 program planned to begin in H2 2026 According to Martin Holst Lange, Chief Scientific Officer of Novo Nordisk, the results reinforce the potential of zenagamtide to expand treatment options for both Type 2 Diabetes and obesity

Burping, even sulfur burps, is not often shown as a side effect of Mounjaro in clinical trials

Sometimes the answer is not push through it. The answer may be to slow the titration, adjust the dose, treat constipation, improve hydration, change eating patterns, or pause and reassess

Normally, about 85-90% of your hair is in anagen at any given time, actively growing